Besides on-target cisplatin resistance, HMGN5 may also be involved in post-target resistance, as its knockdown in prostate cancer cells elicited apoptosis and G2-M cell cycle arrest, leading to the sensitization of ionizing radiation30. The gene discussed is HMGN5; the disease is prostate cancer.